Cargando…

Sorafenib-Associated Heart Failure Complicated by Cardiogenic Shock after Treatment of Advanced Stage Hepatocellular Carcinoma: A Clinical Case Discussion

Background. Sorafenib, an oral tyrosine kinase inhibitor (TKI), targets multiple tyrosine kinase receptors (TKRs) involved in angiogenesis and tumor growth. Studies suggest that inhibition of TKR impacts cardiomyocyte survival. Inhibition of VEGF signaling interrupts angiogenesis and is associated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Candace, Shemisa, Kamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425844/ https://www.ncbi.nlm.nih.gov/pubmed/28536660 http://dx.doi.org/10.1155/2017/7065759

Ejemplares similares

Mechanical Circulatory Support for Acute Heart Failure Complicated by Cardiogenic Shock
por: Choi, Min Suk, et al.
Publicado: (2020)

Predicting survival in patients with acute decompensated heart failure complicated by cardiogenic shock
por: Morici, Nuccia, et al.
Publicado: (2021)

Sacubitril/Valsartanstive Heart Failure: Cardiogenic Shock
por: Rawal, H. A., et al.
Publicado: (2018)

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

The Value of Prolonged QRS in Patients with Heart Failure and Cardiogenic Shock
por: Jang, Se Yong, et al.
Publicado: (2020)

Pheochromocytoma Presenting as Acute Heart Failure Leading to Cardiogenic Shock and Multiorgan Failure
por: Steppan, Jochen, et al.
Publicado: (2011)

Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
por: Zhuang, Lei, et al.
Publicado: (2017)

Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
por: Mousa, Ali Ben
Publicado: (2008)

Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
por: Sanoff, Hanna K., et al.
Publicado: (2016)

Extracorporeal Membrane Oxygenation as a Bridge for Heart Failure and Cardiogenic Shock
por: Zhong, Zhao-peng, et al.
Publicado: (2016)

Cardiac Resynchronization Therapy in Cardiogenic Shock: A Case-Based Discussion
por: Somoza-Cano, Francisco J, et al.
Publicado: (2021)

Nivolumab for Advanced Hepatocellular Carcinoma with Multiple Lung Metastases after Sorafenib Failure
por: Kim, Jaewoong, et al.
Publicado: (2020)

Sorafenib Rechallenge and Sorafenib after Lenvatinib Failure in a Patient with Hepatocellular Carcinoma
por: Ikeda, Atsuyuki, et al.
Publicado: (2021)

Cardiogenic Shock: A Rare Complication of Influenza
por: Hashmi, Arsalan Talib, et al.
Publicado: (2018)

Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib
por: Pomej, Katharina, et al.
Publicado: (2020)

Heart failure and cardiogenic shock associated with the TB-immune reconstitution inflammatory syndrome
por: KENYON, CHRIS, et al.
Publicado: (2012)

Outcome differences in acute vs. acute on chronic heart failure and cardiogenic shock
por: Jones, Tara L., et al.
Publicado: (2020)

Primary Cardiac Lymphoma Presenting with Thrombocytopenia, Right Heart Failure, and Cardiogenic Shock
por: Kurniawan, Samantha, et al.
Publicado: (2023)

Endotoxemia in Acute Heart Failure and Cardiogenic Shock: Evidence, Mechanisms and Therapeutic Options
por: Nguyen, Maxime, et al.
Publicado: (2023)

From Acute heart failure to cardiogenic shock patients requiring admission in ICU
por: Aissaoui, Nadia
Publicado: (2023)

Organ dysfunction, injury, and failure in cardiogenic shock
por: Shirakabe, Akihiro, et al.
Publicado: (2023)

Treatment strategy of adding transcatheter arterial chemoembolization to sorafenib for advanced stage hepatocellular carcinoma
por: Lee, Wei‐Chen, et al.
Publicado: (2020)

Cardiogenic shock /
Publicado: (2002)

Cardiogenic Shock
por: Vahdatpour, Cyrus, et al.
Publicado: (2019)

Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure
por: Rodenas‐Alesina, Eduard, et al.
Publicado: (2023)

Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock
por: Gjesdal, Grunde, et al.
Publicado: (2018)

ANMCO POSITION PAPER: Role of intra-aortic balloon pump in patients with acute advanced heart failure and cardiogenic shock
por: Rossini, Roberta, et al.
Publicado: (2021)

Advanced Metrics and Early Predictors of Cardiogenic Shock
por: Shah, Nisarg, et al.
Publicado: (2023)

Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
por: SHAO, WENBO, et al.
Publicado: (2014)

Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma
por: Huang, Song-Fong, et al.
Publicado: (2022)

Treatment options after sorafenib failure in patients with hepatocellular carcinoma
por: Dika, Imane El, et al.
Publicado: (2017)

Pre-sarcopenia determines post-progression outcomes in advanced hepatocellular carcinoma after sorafenib failure
por: Cheng, Tsung-Yi, et al.
Publicado: (2020)

Prognostic Value of QRS Duration among Patients with Cardiogenic Shock Complicating Acute Heart Failure: Data from the Korean Acute Heart Failure (KorAHF) Registry
por: Hong, Jung Ae, et al.
Publicado: (2020)

Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis
por: Chen, Shuling, et al.
Publicado: (2018)

Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma
por: Hsiao, Pojen, et al.
Publicado: (2019)

Effect of Cardiogenic Shock Hospital Volume on Mortality in Patients With Cardiogenic Shock
por: Shaefi, Shahzad, et al.
Publicado: (2015)

Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock
por: Orrem, Hilde L., et al.
Publicado: (2018)

Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma
por: Lee, Sangheun, et al.
Publicado: (2013)

Camrelizumab Plus Sorafenib Versus Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Analysis
por: Liu, Qinqin, et al.
Publicado: (2021)

Emerging concepts in heart failure management and treatment: focus on point-of-care ultrasound in cardiogenic shock
por: Ruben, Mariela, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rqlpfk6nhm8f9cienol2069c14